MESO Overview

Company Profile

Related stocks

MSB.AX • Australia

MESOBLAST FPO [MSB]

2 AUD

1.81B USD 1Y -32.2%

PYC.AX • Australia

PYC THERAP FPO [PYC]

2.45 AUD

1.68B USD 1Y +109.4%

ONESOURCE.NS • India

ONESOURCE SPECL PHARMA L

1,461.3 INR

1.73B USD 1Y -22.7%

NEU.AX • Australia

NEUREN FPO NZ [NEU]

20.2 AUD

1.79B USD 1Y -5.3%

9606.HK • China

DUALITYBIO-B

182.7 HKD

2.13B USD 1Y -42.1%

TLX.AX • Australia

TELIXPHARM FPO [TLX]

15.85 AUD

3.75B USD 1Y +2.9%

302440.KS • South Korea

SKBS

36,750 KRW

2.15B USD 1Y -22.6%

688202.SS • China

SHANGHAI MEDICILON INC

104 CNY

2.09B USD 1Y +53.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

86.2% p.a.

Max Drawdown (5Y)

-87.9%

Sharpe Ratio (5Y)

0.02

Beta Factor

0.86

Size Class

Small Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (86.2% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -95.7% in the extended horizon.